Ocular Toxicity With New Drugs for Gynecologic Cancers

Antibody-drug conjugates are a promising new option for gynecologic cancers, but they have a variety of ocular or vision-related adverse events that need to be appropriately monitored and managed.
Medscape Medical News

Full Story →